首页> Clinical cancer research : an official journal of the American Association for Cancer Research> A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer.

A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： David,Pook

第一单位： Cabrini Monash University Department of Medical Oncology, Cabrini Health, Malvern, Victoria, Australia.

作者： David,Pook ^[1] ; Daniel M,Geynisman ^[2] ; Joan,Carles ^[3] ; Filippo,de Braud ^[4] ; Anthony M,Joshua ^[5] ; José Luis,Pérez-Gracia ^[6] ; Casilda,Llácer Pérez ^[7] ; Sang Joon,Shin ^[8] ; Bruno,Fang ^[9] ; Minal,Barve ^[10] ; Marco,Maruzzo ^[11] ; Sergio,Bracarda ^[12] ; Miso,Kim ^[13] ; Yannick,Kerloeguen ^[14] ; Jorge Daniel,Gallo ^[14] ; Sophia L,Maund ^[15] ; Adam,Harris ^[15] ; Kuan-Chieh,Huang ^[15] ; Victor,Poon ^[15] ; Dhruvitkumar S,Sutaria ^[15] ; Howard,Gurney ^[16]

作者单位： Cabrini Monash University Department of Medical Oncology, Cabrini Health, Malvern, Victoria, Australia. ^[1] Medical Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania. ^[2] Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. ^[3] Oncologia Medica, Istituto Nazionale dei Tumori di Milano, Milan, Italy. ^[4] Kinghorn Cancer Centre, Saint Vincent's Hospital, Darlinghurst, New South Wales, Australia. ^[5] Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain. ^[6] Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain. ^[7] Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea. ^[8] Astera Cancer Care, East Brunswick, New Jersey. ^[9] Mary Crowley Cancer Research Center, Dallas, Texas. ^[10] Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. ^[11] Medical and Translational Oncology Unit, Department of Oncology, Azienda Ospedaliera Santa Maria, Terni, Italy. ^[12] Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. ^[13] F. Hoffmann-La Roche Ltd, Basel, Switzerland. ^[14] Genentech Inc, South San Francisco, California. ^[15] Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia. ^[16]

医学主题词男(雄)性(Male);人类(Humans);前列腺特异抗原(Prostate-Specific Antigen);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols)

DOI 10.1158/1078-0432.CCR-22-2585

PMID 37339186

发布时间 2023-11-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交